Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Masatoshi Jinnin. (2013) Contribution of miRNAs to the pathogenesis of scleroderma and targeting them for the diagnosis and treatment. Expert Review of Dermatology 8:4, pages 417-426.
Read now
Read now
Timothy RDJ Radstake. (2011) Novel insights in the pathogenesis of systemic sclerosis. Expert Review of Clinical Immunology 7:4, pages 389-390.
Read now
Read now
Articles from other publishers (18)
Yena Kim, Yoojun Nam, Yeri Alice Rim & Ji Hyeon Ju. (2022) Anti-fibrotic effect of a selective estrogen receptor modulator in systemic sclerosis. Stem Cell Research & Therapy 13:1.
Crossref
Crossref
Zhanying Hou, Xuehan Su, Guangming Han, Ruzeng Xue, Yangxia Chen, Ye Chen, Huan Wang, Bin Yang, Yunsheng Liang & Suyun Ji. (2022) JAK1/2 Inhibitor Baricitinib Improves Skin Fibrosis and Digital Ulcers in Systemic Sclerosis. Frontiers in Medicine 9.
Crossref
Crossref
Ziyi Chen, Jan Dudek, Christoph Maack & Ulrich Hofmann. (2021) Pharmacological inhibition of GLUT1 as a new immunotherapeutic approach after myocardial infarction. Biochemical Pharmacology 190, pages 114597.
Crossref
Crossref
Konstantinos Melissaropoulos & Dimitrios Daoussis. (2021) B cells in systemic sclerosis: from pathophysiology to treatment. Clinical Rheumatology 40:7, pages 2621-2631.
Crossref
Crossref
Andrea De Pieri, Benjamin D. Korman, Astrid Jüngel & Karin Wuertz‐Kozak. (2021) Engineering Advanced In Vitro Models of Systemic Sclerosis for Drug Discovery and Development. Advanced Biology 5:4, pages 2000168.
Crossref
Crossref
A. Prasse, F. Bonella, U. Müller-Ladner, T. Witte, N. Hunzelmann & J. Distler. (2019) Therapie der systemischen Sklerose-assoziierten interstitiellen LungenerkrankungTreatment of systemic sclerosis-associated interstitial lung disease. Zeitschrift für Rheumatologie 79:3, pages 294-303.
Crossref
Crossref
Zhenyu Sun, Wenjuan Wang, Degang Yu & Yuanqing Mao. (2019) Differentially expressed genes between systemic sclerosis and rheumatoid arthritis. Hereditas 156:1.
Crossref
Crossref
Predrag Ostojic, Katarina Jankovic, Nada Djurovic, Biljana Stojic, Sladjana Knezevic-Apostolski & Daniela Bartolovic. (2019) Common Causes of Pain in Systemic Sclerosis: Frequency, Severity, and Relationship to Disease Status, Depression, and Quality of Life. Pain Management Nursing 20:4, pages 331-336.
Crossref
Crossref
Benjamin Chaigne, Guilhem Clary, Morgane Le Gall, Nicolas Dumoitier, Claire Fernandez, Sebastien Lofek, Philippe Chafey, Pia Moinzadeh, Thomas Krieg, Christopher P. Denton & Luc Mouthon. (2018) Proteomic Analysis of Human Scleroderma Fibroblasts Response to Transforming Growth Factor‐ß. PROTEOMICS – Clinical Applications 13:4, pages 1800069.
Crossref
Crossref
Lina Ren, Yi Zhao, Xiaoxi Huo & Xin Wu. (2018) MiR-155-5p promotes fibroblast cell proliferation and inhibits FOXO signaling pathway in vulvar lichen sclerosis by targeting FOXO3 and CDKN1B. Gene 653, pages 43-50.
Crossref
Crossref
Matthew J. Turner. 2017. Clinical and Basic Immunodermatology. Clinical and Basic Immunodermatology
239
264
.
Jingang Huang, Christian Beyer, Katrin Palumbo-Zerr, Yun Zhang, Andreas Ramming, Alfiya Distler, Kolja Gelse, Oliver Distler, Georg Schett, Lutz Wollin & Jörg H W Distler. (2016) Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis. Annals of the Rheumatic Diseases 75:5, pages 883-890.
Crossref
Crossref
Polona Žigon, Katjuša Mrak-Poljšak, Katja Lakota, Matic Terčelj, Saša Čučnik, Matija Tomsic & Snezna Sodin-Semrl. (2016) Metabolic fingerprints of human primary endothelial and fibroblast cells. Metabolomics 12:5.
Crossref
Crossref
Jasmin Raja & Christopher Paul Denton. (2015) Cytokines in the immunopathology of systemic sclerosis. Seminars in Immunopathology 37:5, pages 543-557.
Crossref
Crossref
José Manuel López-Cacho, Soledad Gallardo, Manuel Posada, Miriam Aguerri, David Calzada, Teodoro Mayayo, María Luisa González-Rodríguez, Antonio María Rabasco, Carlos Lahoz & Blanca Cárdaba. (2014) Association of Immunological Cell Profiles with Specific Clinical Phenotypes of Scleroderma Disease. BioMed Research International 2014, pages 1-8.
Crossref
Crossref
Yuko Ota, Yasushi Kawaguchi, Kae Takagi, Hisae Ichida, Takahisa Gono, Masanori Hanaoka, Tomoaki Higuchi & Hisashi Yamanaka. (2013) Ghrelin attenuates collagen production in lesional fibroblasts from patients with systemic sclerosis. Clinical Immunology 147:2, pages 71-78.
Crossref
Crossref
Florian Kollert, Sophie Christoph, Corina Probst, Stephan Budweiser, Bettina Bannert, Moritz Binder, Bettina Sehnert, Reinhard E. Voll, Klaus Warnatz, Gernot Zissel, Ulrich A. Walker, Antje Prasse & Anja Saalbach. (2013) Soluble CD90 as a potential marker of pulmonary involvement in systemic sclerosis. Arthritis Care & Research 65:2, pages 281-287.
Crossref
Crossref
STYLIANOS T. PANOPOULOS, VASILIKI-KALLIOPI BOURNIA & PETROS P. SFIKAKIS. (2013) Is Vasculopathy Associated with Systemic Sclerosis More Severe in Men?. The Journal of Rheumatology 40:1, pages 46-51.
Crossref
Crossref